These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17984336

  • 1. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL, Stefani MM, Pereira GA, Costa MB, Rebello PF, Gomes MK, Narahashi K, Gillis TP, Krahenbuhl JL, Martelli CM.
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 7. In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression.
    Stefani MM, Martelli CM, Gillis TP, Krahenbuhl JL, Brazilian Leprosy Study Group.
    J Infect Dis; 2003 Oct 01; 188(7):1024-31. PubMed ID: 14513423
    [Abstract] [Full Text] [Related]

  • 8. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K, Katoch VM, Natarajan M, Gupta UD, Sharma VD, Singh HB.
    Indian J Lepr; 2008 Oct 01; 80(4):331-44. PubMed ID: 20329382
    [Abstract] [Full Text] [Related]

  • 9. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R, Revankar CR, Pai VV, Kingsley S.
    Int J Lepr Other Mycobact Dis; 1999 Sep 01; 67(3):308-9. PubMed ID: 10575413
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR, Pai VV, Samy MS, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep 01; 67(3):312-4. PubMed ID: 10575415
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Histopathological activity in paucibacillary leprosy patients after ROM therapy.
    Ebenezer GJ, Job CK.
    Int J Lepr Other Mycobact Dis; 1999 Dec 01; 67(4):409-13. PubMed ID: 10700915
    [Abstract] [Full Text] [Related]

  • 14. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR, Dhurat RS, Jerajani HR.
    Indian J Lepr; 2003 Dec 01; 75(3):209-17. PubMed ID: 15267190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.